Philippe Rodon

Perigueux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

Journal: American journal of hematology

Published: April 05, 2022

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.

Journal: Leukemia

Published: May 18, 2021

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Journal: Blood

Published: September 17, 2020

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2019

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Journal: American journal of hematology

Published: February 08, 2019

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 06, 2018

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Journal: Leukemia

Published: October 05, 2018

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

Journal: Leukemia

Published: March 13, 2018

Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.

Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.

Journal: The Lancet. Haematology

Published: October 07, 2017

Evaluation of infectious prevention practices in myeloma

Evaluation of infectious prevention practices in myeloma

Journal: Medecine et maladies infectieuses

Published: September 13, 2017

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.

Journal: Annals of hematology

Published: January 03, 2017

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Journal: Blood

Published: July 08, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026